Iron: Not Just a Passive Bystander in AITD

Nutrients. 2022 Nov 5;14(21):4682. doi: 10.3390/nu14214682.

Abstract

Autoimmune thyroid disease (AITD) is the most prevalent autoimmune disease all over the world and the most frequent cause of hypothyroidism in areas of iodine sufficiency. The pathogenesis of AITD is multifactorial and depends on complex interactions between genetic and environmental factors, with epigenetics being the crucial link. Iron deficiency (ID) can reduce the activities of thyroid peroxidase and 5'-deiodinase, inhibit binding of triiodothyronine to its nuclear receptor, and cause slower utilization of T3 from the serum pool. Moreover, ID can disturb the functioning of the immune system, increasing the risk of autoimmune disorders. ID can be responsible for residual symptoms that may persist in patients with AITD, even if their thyrometabolic status has been controlled. The human lifestyle in the 21st century is inevitably associated with exposure to chemical compounds, pathogens, and stress, which implies an increased risk of autoimmune disorders and thyroid dysfunction. To summarize, in our paper we discuss how iron deficiency can impair the functions of the immune system, cause epigenetic changes in human DNA, and potentiate tissue damage by chemicals acting as thyroid disruptors.

Keywords: AITD; iron deficiency; thyroid.

Publication types

  • Review

MeSH terms

  • Autoimmune Diseases* / etiology
  • Hashimoto Disease*
  • Humans
  • Iron
  • Thyroid Diseases* / etiology

Substances

  • Iron

Grants and funding

This research received no external funding.